Overview
Takahiko Shibahara practices in Chiyoda, Japan. Shibahara is rated as an Experienced expert by MediFind in the treatment of Conversion Disorder. Their top areas of expertise are Tongue Cancer, Oral Squamous Cell Carcinoma, Nevoid Basal Cell Carcinoma Syndrome, Osteotomy, and Bone Graft.
Their clinical research consists of co-authoring 107 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Conversion Disorder.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Tongue CancerShibahara isDistinguished. Learn about Tongue Cancer.
- Advanced
- Nevoid Basal Cell Carcinoma Syndrome
- Oral Squamous Cell CarcinomaShibahara isAdvanced. Learn about Oral Squamous Cell Carcinoma.
- OsteonecrosisShibahara isAdvanced. Learn about Osteonecrosis.
- OsteotomyShibahara isAdvanced. Learn about Osteotomy.
- Experienced
- Adenoid Cystic CarcinomaShibahara isExperienced. Learn about Adenoid Cystic Carcinoma.
- Basal Cell Skin CancerShibahara isExperienced. Learn about Basal Cell Skin Cancer.
- Bone GraftShibahara isExperienced. Learn about Bone Graft.
- Bone TumorShibahara isExperienced. Learn about Bone Tumor.
- Conversion DisorderShibahara isExperienced. Learn about Conversion Disorder.
- Fibrous DysplasiaShibahara isExperienced. Learn about Fibrous Dysplasia.